JA
Jazz Pharmaceuticals plc
JAZZ · NASDAQ
$240.83 -2.42% (-$5.98)
1M -3.03%
Market Cap $15.1B
P/E Ratio 16.08x
Div. Yield -
ROE 21.37%
Bulios Fair Price
$239.61
0.5% downside
Trenutna cena
$240.83
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price se delnica JAZZ trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
75 /100
Cheap EV/EBITDA 12.14x
P/S 3.29x
P/B 3.15x
Growth
68 /100
Growing FCF growth 18.79%
Book val. growth 11.86%
Rev. growth 5.26%
Profitability
100 /100
Strong Net margin 20.45%
Op. margin 31.05%
FCF margin 33.52%
Quality
84 /100
Excellent ROE 21.37%
ROA 8.49%
Asset turnover 0.42x
Debt
64 /100
Moderate Current ratio 1.78x
Int. coverage 4.74x
Net debt/EBITDA 1.89x
Stability
39 /100
Moderate Rev. volatility 0.75%
EPS volatility 219.02%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o JAZZ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Renee D. Gala
Employees
2,890
Headquarters
Dublin
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report